apixabanum teva 2,5 mg tabletki powlekane
teva pharmaceuticals polska sp. z o.o. - apiksaban - tabletki powlekane - 2,5 mg
apixabanum teva 5 mg tabletki powlekane
teva pharmaceuticals polska sp. z o.o. - apiksaban - tabletki powlekane - 5 mg
astmirex 4 mg tabletki do rozgryzania i żucia
exeltis poland sp. z o.o. - montelukastum - tabletki do rozgryzania i żucia - 4 mg
astmirex 5 mg tabletki do rozgryzania i żucia
exeltis poland sp. z o.o. - montelukastum - tabletki do rozgryzania i żucia - 5 mg
astmirex 10 mg tabletki powlekane
exeltis poland sp. z o.o. - montelukastum - tabletki powlekane - 10 mg
famenita 100 mg kapsułki miękkie
laboratoire effik - progesteronum - kapsułki miękkie - 100 mg
famenita 200 mg kapsułki miękkie
laboratoire effik - progesteronum - kapsułki miękkie - 200 mg
phelinun
adienne s.r.l. s.u. - melphalan hydrochloride - multiple myeloma; hodgkin disease; lymphoma, non-hodgkin; precursor cell lymphoblastic leukemia-lymphoma; leukemia, myeloid, acute; neuroblastoma; ovarian neoplasms; hematopoietic stem cell transplantation - Środki przeciwnowotworowe - high-dose of phelinun used alone or in combination with other cytotoxic medicinal products and/or total body irradiation is indicated in the treatment of:multiple myeloma,malignant lymphoma (hodgkin, non-hodgkin lymphoma),acute lymphoblastic and myeloblastic leukemia,childhood neuroblastoma,ovarian cancer,mammary adenocarcinoma. phelinun in combination with other cytotoxic medicinal products is indicated as reduced intensity conditioning (ric) treatment prior to allogeneic haematopoietic stem cell transplantation (allo-hsct) in malignant haematological diseases in adults. phelinun in combination with other cytotoxic medicinal products is indicated as conditioning regimen prior to allogeneic haematopoietic stem cell transplantation in haematological diseases in the paediatric population as:myeloablative conditioning (mac) treatment in case of malignant haematological diseasesric treatment in case of non-malignant haematological diseases.
prialt
esteve pharmaceuticals gmbh - zykonotyd - injections, spinal; pain - Środki przeciwbólowe - zykonotyd jest wskazany w leczeniu ciężkiego, przewlekłego bólu u pacjentów wymagających znieczulenia dooponowego (it).
thiotepa riemser
esteve pharmaceuticals gmbh - tiotepa - hematopoietic stem cell transplantation; neoplasms - Środki przeciwnowotworowe - thiotepa riemser is indicated, in combination with other chemotherapy medicinal products:with or without total body irradiation (tbi), as conditioning treatment prior to allogeneic or autologous haematopoietic progenitor cell transplantation (hpct) in haematological diseases in adult and paediatric patients;when high dose chemotherapy with hpct support is appropriate for the treatment of solid tumours in adult and paediatric patients. thiotepa riemser is indicated, in combination with other chemotherapy medicinal products:with or without total body irradiation (tbi), as conditioning treatment prior to allogeneic or autologous haematopoietic progenitor cell transplantation (hpct) in haematological diseases in adult and paediatric patients;when high dose chemotherapy with hpct support is appropriate for the treatment of solid tumours in adult and paediatric patients.